Spotlight On... PSI touts its hematology expertise; Wockhardt clears U.K. regulators; Infinity taps Medidata; and much more...

Swiss CRO PSI is headed to this weekend's American Society of Hematology meeting, touting its experience in trials for breakthrough treatments for blood cancers. News

> Indian drug manufacturer Wockhardt said it received U.K. clearance for a troubled production plant in Chikalthana. More

> Infinity Pharmaceuticals ($INFI) enlisted Medidata ($MDSO) to help execute its Phase III cancer trial. Story

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.